# GlaxoSmithKline LLC – FDA Inspection, Apr 21, 2016

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/cc81defe-1000-49a7-8e5a-3c8096621bd1
Source feed: FDA_Inspections

> FDA inspection 987392 of GlaxoSmithKline LLC, April 21, 2016. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 211. 8 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 987392
- Company Name: GlaxoSmithKline LLC
- Inspection Date: 2016-04-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1298596 - 2026-02-20
- [FDA Inspection 1229588 - 2024-04-19](https://www.keypedia.com/records/fda_inspections/glaxosmithkline-llc/d81fd5bf-3526-4a54-88e1-61ea98c30e1d)
- FDA Inspection 1043270 - 2018-01-26
- FDA Inspection 940149 - 2015-08-21
- FDA Inspection 841675 - 2013-05-03

Company: https://www.keypedia.com/companies/glaxosmithkline-llc/66fdfcfe-6173-4e09-abb4-df089ede2996

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c